Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IWOT: Early Treatment vs Surveillance in IDH-Mutated Glioma
NCT03763422Phase 3Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Mar 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of temozolomide in astrocytoma, sponsored by European Organisation for Research and Treatment of Cancer. Started Mar 2020; status: terminated.
02
Drugs
temozolomide
03
Conditions
astrocytoma
Beyond the preview
Go deeper on NCT03763422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03763422.